Biotechnology Jobs

GSK · Waltham, United States · US$340,500 – US$567,500 pa

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability across major markets. Builds and directs a matrix Medicine Development Team spanning clinical development, immunology/biomarkers, manufacturing, regulatory, safety, medical affairs and commercial, and represents the asset to senior governance boards.

GSK · Stevenage · US$340,500 – US$567,500 pa

Leads global development of a cancer vaccine asset from late-stage transition through approval and launch, acting as single point of accountability. Builds and leads a matrix Medicine Development Team spanning clinical development, immunology, manufacturing, regulatory, safety, medical affairs and commercial, and sets the asset strategy within GSK's oncology R&D portfolio.

Isomorphic Labs · London

Lead all externalised drug discovery and preclinical lab operations, building and scaling a global CRO infrastructure for an AI-first drug design platform. Oversee experimental throughput, data QC and turnaround times, embed data-generation-by-design standards, and manage vendor governance, budgets and a team of CRO Scientific Leads, Operations Managers and Compound Managers.

CSL · Waltham, United States

Leads an integrated quality assurance organisation covering Good Clinical Practice and Good Pharmacovigilance Practice, reporting to the Head of Global R&D Quality. Sets strategy, operating model and standards for risk-based QA oversight from trial design through close-out, including inspection readiness, CAPAs and clinical safety interfaces such as SAE reconciliation and expedited reporting. Hybrid role with global team leadership and international travel.

CSL · Opfikon, Switzerland

Leads strategic sourcing and evaluation of late-stage external clinical assets in Immunology, from Phase 2 through marketed drugs. Sits on the Therapy Area Leadership Team, co-leads New Product Opportunity reviews, engages external KOLs and investigators, and drives cross-functional due diligence with BD to close deals.

Isomorphic Labs · Cambridge, United States

Lead and execute the translational medicine strategy for an oncology portfolio, ensuring clinical biomarker assay readiness and data delivery to inform mechanism of action, resistance and future indications. Serve as a core program team member and cancer biology expert, collaborating with AI and computational biology teams to build innovative biomarker analysis tools and advance companion diagnostics.

Recursion · Remote Opportunity - United States · US$261,800 – US$346,060 pa

Lead clinical pharmacology and pharmacometrics strategy across a portfolio of rare disease and oncology programs, serving as the clinical pharmacology lead and regulatory representative. Oversee modeling and simulation (population PK, PK-PD, exposure-response) and provide pharmacology input on Phase 1-3 study designs. Work cross-functionally with clinical, translational and discovery teams in an end-to-end drug development environment.

Moderna · London

Shape global CMC regulatory strategy for an innovative mRNA medicines portfolio, driving international submissions and health authority interactions. Prepare and review CMC sections of regulatory filings, advise Manufacturing and Quality teams, and oversee multiple development programs. An individual contributor role with global reach, working alongside teams using digital and Generative AI tools.

SRG · Darlington · £65,000 – £85,000 pa

Lead multidisciplinary operational teams across two sites, covering operations, engineering, facilities and site services. Drive continuous improvement, GMP and H&S compliance, facilities management, budgets and capital projects supporting biologics, RNA and medicines manufacturing. Senior leadership role shaping facility strategy and operational capability.

Bicycle Therapeutics · Cambridge

Operational backbone of R&D Quality, administering and optimising a validated eQMS (Veeva, TrackWise, Dot Compliance) for GxP document control, training matrices, deviation/CAPA tracking and inspection readiness. Supports FDA, MHRA and EMA inspections and works across clinical, non-clinical and pharmacovigilance teams.

Moderna · London

Lead CMC regulatory strategy for UK-manufactured and UK-licensed mRNA products across development, registration and post-approval lifecycle. Act as primary point of contact with the MHRA, oversee submissions and manufacturing change assessments, and shape global regulatory approaches across cross-functional matrix teams.

Evotec · Abingdon

Owns Evotec's in silico therapeutics design capability, uniting computational chemistry, generative and modality design (small molecules, peptides, protein engineering, degraders, molecular glues) and predictive ADMET/safety under one mandate. A newly created unit within the In Silico & AI group with an explicit build mandate: set technical vision, grow a multi-site team, and industrialise repeatable, benchmarked methods across partner programmes.

Evotec · Abingdon

Acts as the single front door between Global Biology Operations and the In Silico & AI organisation, owning demand, the in silico roadmap and delivery orchestration across computational biology, bioinformatics and AI teams. Focuses on Disease-to-Target and applying the proprietary E.MPD multi-omics resource to target identification, validation and patient stratification, while evidencing value and supporting client proposals.

Relation Therapeutics · London

Lead clinical pharmacology and pharmacometrics across a growing drug discovery portfolio, serving as the quantitative lead on cross-functional project teams. Apply MIDD, PBPK, population PK/PD and QSP modelling to translate nonclinical data into human dosing and trial design, spanning small molecules, biologics and novel platforms. Also manages CRO partnerships and authors regulatory submissions.